Clinical Trials List
2026-09-01 - 2029-06-30
Phase II
Not yet recruiting4
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/08/01
Investigators and Locations
Co-Principal Investigator
- 謝明哲 Division of Cardiovascular Diseases
- 陳俊吉 Division of Cardiovascular Diseases
- 何明昀 Division of Cardiovascular Diseases
- 葉日凱 Division of Cardiovascular Diseases
- 張伯丞 Division of Cardiovascular Diseases
- 陳東藝 Division of Cardiovascular Diseases
- 沃宏達 Division of Cardiovascular Diseases
- 王朝永 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 何鴻鋆 Division of Cardiovascular Diseases
- Shang-Ju Wu Division of Cardiovascular Diseases
- 王奇彥 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 林重佑 Division of Cardiovascular Diseases
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
16 participants
-
Global
525 participants
